Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
2002 1
2004 1
2005 1
2006 1
2008 1
2012 3
2013 1
2019 1
2020 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Acute Megakaryoblastic Leukemia"
Page 1
Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Pastore F, Gittinger H, Raab S, Tschuri S, Ksienzyk B, Konstandin NP, Schneider S, Rothenberg-Thurley M, Horny HP, Werner M, Sauerland MC, Amler S, Görlich D, Berdel WE, Wörmann B, Braess J, Hiddemann W, Tischer J, Herold T, Metzeler KH, Spiekermann K. Pastore F, et al. Br J Haematol. 2023 Sep;202(6):1165-1177. doi: 10.1111/bjh.18982. Epub 2023 Jul 16. Br J Haematol. 2023. PMID: 37455345
Acute megakaryoblastic leukaemia (AMKL) is associated with poor prognosis. Limited information is available on its cytogenetics, molecular genetics and clinical outcome. We performed genetic analyses, evaluated prognostic factors and the value of allog …
Acute megakaryoblastic leukaemia (AMKL) is associated with poor prognosis. Limited information is available on its cyto …
Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
Qi H, Mao Y, Cao Q, Sun X, Kuai W, Song J, Ma L, Hong Z, Hu J, Zhou G. Qi H, et al. Med Sci Monit. 2020 Jun 13;26:e922662. doi: 10.12659/MSM.922662. Med Sci Monit. 2020. PMID: 32532951 Free PMC article.
BACKGROUND The aim of this study was to investigate the clinical features and prognostic factors of childhood acute megakaryoblastic leukemia (AMKL). ...Five patients died after transplantation, 4 of whom died due to recurrence after transplanta …
BACKGROUND The aim of this study was to investigate the clinical features and prognostic factors of childhood acute megakar …
Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review.
Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, Iida K, Nakayama N, Ishikura H, Miyazaki K. Yeasmin S, et al. Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1371-6. doi: 10.1111/j.1525-1438.2007.01185.x. Epub 2008 Jan 23. Int J Gynecol Cancer. 2008. PMID: 18217963 Review.
Alkylating agents have strong leukemogenic potential. There are a number of recent acute myeloid leukemia (t-AML) cases related to previous paclitaxel exposure. ...Unlike previously reported cases, the present case was of the secondary acute megakaryoblast …
Alkylating agents have strong leukemogenic potential. There are a number of recent acute myeloid leukemia (t-AML) cases relate …
Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A, Peeters M, Poon A. Zipursky A, et al. Pediatr Hematol Oncol. 1987;4(3):211-30. doi: 10.3109/08880018709141272. Pediatr Hematol Oncol. 1987. PMID: 2978961 Review.
The following conclusions have been reached: (1) approximately 20% of leukemia (excluding transient leukemia) in Down's syndrome is acute megakaryoblastic leukemia; (2) approximately 20% of all leukemia in Down's syndrome is transient …
The following conclusions have been reached: (1) approximately 20% of leukemia (excluding transient leukemia) in Down's syndro …
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.
Janjetovic S, Bacher U, Haalck T, Janning M, Bokemeyer C, Fiedler W. Janjetovic S, et al. Acta Haematol. 2013;129(2):121-5. doi: 10.1159/000342897. Epub 2012 Nov 28. Acta Haematol. 2013. PMID: 23207728
Normal individuals harboring XPD polymorphisms are at increased risk for developing acute lymphoblastic leukemia and acute myeloid leukemia (AML). CASE REPORT: A 33-year-old male XP patient was diagnosed with acute megakaryoblastic leu …
Normal individuals harboring XPD polymorphisms are at increased risk for developing acute lymphoblastic leukemia and acute …
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.
Sasaki H, Mitani S, Kusumoto S, Marumo Y, Asano A, Yoshida T, Narita T, Ito A, Yano H, Ri M, Ishida T, Komatsu H, Iida S. Sasaki H, et al. Int J Hematol. 2019 Jul;110(1):119-123. doi: 10.1007/s12185-019-02628-8. Epub 2019 Mar 16. Int J Hematol. 2019. PMID: 30879266
A 42-year-old female complaining of fever and night sweats was diagnosed with acute megakaryoblastic blast phase chronic myeloid leukemia (CML-BP). She had massive splenomegaly, left pleural effusion with leukemia infiltration, and moderate myelofibros …
A 42-year-old female complaining of fever and night sweats was diagnosed with acute megakaryoblastic blast phase chronic myelo …
Acute megakaryoblastic leukemia with increased hematogones in children.
Anton-Harisi M, Douna V, Baka M, Servitzoglou M, Kosmidis HV, Georgouli H, Anastasiou T. Anton-Harisi M, et al. J Pediatr Hematol Oncol. 2012 Nov;34(8):e337-40. doi: 10.1097/MPH.0b013e3182678ddb. J Pediatr Hematol Oncol. 2012. PMID: 22983420
We describe 2 patients, a 4-month-old male and a 17-month-old female, with de novo acute megakaryoblastic leukemia with increased number of hematogones at diagnosis. ...The bone marrow smears in the first child revealed the presence of 60% cells with morpholo …
We describe 2 patients, a 4-month-old male and a 17-month-old female, with de novo acute megakaryoblastic leukemia with …
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Blood. 1988 Apr;71(4):992-6. Blood. 1988. PMID: 3162695 Free article.
Thirty-five patients with acute myelogenous leukemia were treated with aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213 (100 mg/m2/day for 5 days). ...Most patients (28) had received prior DAT (daunorubicin, cytosine arabinoside, and 6-thioguanine) induction …
Thirty-five patients with acute myelogenous leukemia were treated with aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213 …
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).
Garderet L, Labopin M, Gorin NC, Polge E, Baruchel A, Meloni G, Ortega J, Vossen J, Bunjes D, Leverger G, Blaise D, Ferrant A, Brune M, Dore E, Gadner H, Zintl F, Yaniv I, Dini G, Frassoni F; Acute Leukemia Working Party and Pediatric Working Party of the European Group for Blood and Marrow Transplantation. Garderet L, et al. Blood. 2005 Jan 1;105(1):405-9. doi: 10.1182/blood-2004-03-1103. Epub 2004 Jun 10. Blood. 2005. PMID: 15191953 Free article.
Acute megakaryoblastic leukemia (M7 AML) is a highly aggressive disease. ...Results for autologous transplantation were (children and adults, respectively): engraftment, 90% and 100%; 3-year treatment-related mortality (TRM) rate, 3% and 8%; relapse rate, 45% …
Acute megakaryoblastic leukemia (M7 AML) is a highly aggressive disease. ...Results for autologous transplantation were …
Long-term follow-up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high-risk acute myeloid leukaemia: Report from a single centre.
Bai L, Zhang ZX, Hu GH, Cheng YF, Suo P, Wang Y, Yan CH, Sun YQ, Chen YH, Chen H, Liu KY, Xu LP, Huang XJ. Bai L, et al. Br J Haematol. 2024 Feb;204(2):585-594. doi: 10.1111/bjh.19086. Epub 2023 Sep 2. Br J Haematol. 2024. PMID: 37658699
Data from 200 children with high-risk acute myeloid leukaemia who underwent their first haploidentical haematopoietic stem cell transplantation (haplo-HSCT) between 2015 and 2021 at our institution were analysed. ...The 4-year OS, EFS and CIR differed significantly between …
Data from 200 children with high-risk acute myeloid leukaemia who underwent their first haploidentical haematopoietic stem cell trans …
14 results